Skip to content

Evaluation of the FeverApp as a documentation and information tool for the FeverApp registry during acute febrile episodes in children: Impact on parental decision-making and fever management in children aged three months to six years.

Evaluation of the FeverApp as a documentation and information tool for the FeverApp registry during acute febrile episodes in children: Impact on parental decision-making and fever management in children aged three months to six years.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00035610
Enrollment
180
Registered
2025-05-30
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R50

Interventions

Group 1: Intervention group: Participants in this group could use the FeverApp during their children's febrile episodes. The app is used to document temperature progression, symptoms, medication intak

Sponsors

Private Universität Witten/Herdecke, Gerhard-Kienle-Lehrstuhl c/o Gemeinschaftskrankenhaus, Dornbuschhaus, Etage 5
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Months to 6 Years

Inclusion criteria

Inclusion criteria: Informed Consent: Participants (parents) are able to provide informed consent and understand the nature of the study as well as their involvement in it.

Exclusion criteria

Exclusion criteria: Lack of Consent: Children whose parents or legal guardians do not provide consent to participate in the study. No Access to Internet or Smartphone: Lack of access to the internet or a smartphone.

Design outcomes

Primary

MeasureTime frame
The frequency of antipyretic use per febrile episode, with an episode considered complete when the child has been fever-free for 48 consecutive hour

Secondary

MeasureTime frame
- Safety: How safe do you currently feel in dealing with your child's fever? (Likert 1-5): daily during a fever episode and at the beginning and end of the overall study - Well-being: How is your child ( Likert 1-5) daily during a fever episode - Episode duration in days

Countries

Germany

Contacts

Public ContactDennis Nigge

Barbara Apotheke Kamen

dennis.nigge@barbara-apotheke-heeren.de+49 177 5603660

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026